BUY Strides Pharma Science Limited — Geojit Financial Services
byGeojit Financial ServicesHorizon: NA (inferred 1 year)2 Jul 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·21 Oct · yesterday
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Strides Pharma Science
- BUY — Rakesh Bansal21 Sept 2026 · ~2 weeks · target ₹1,278 · SL hit
- BUY — Nirav Chheda, Nirmal Bang Securities8 Sept 2026 · ~2 weeks · target ₹1,250 · SL hit
- BUY — Nilesh Jain, Centrum Broking7 Sept 2026 · ~3 months · target ₹1,200 · Target hit
- BUY — Rajesh Satpute29 Jun 2026 · ~2 weeks · target ₹1,150 · SL hit
- BUY — Sachin Gupta6 May 2026 · ~3 months · target ₹1,150 · Target hit
More from Geojit Financial Services
- BUY Tata Consultancy Services14 Oct 2026 · ~1 year · target ₹2,530 · Target hit
- BUY Apex Frozen Foods6 Oct 2026 · ~1 year · target ₹430 · Active
- BUY Ashok Leyland29 Sept 2026 · ~1 year · target ₹179 · Active
- BUY Sun Pharmaceutical Industries21 Sept 2026 · ~1 year · target ₹2,070 · Active
- BUY Tata Motors17 Sept 2026 · ~1 year · target ₹482 · Active

